This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: SARS-CoV-2
Check out our new article: ‘Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines’ – OPEN ACCESS
May 30, 2024Borrajo, M.L., Lou, G., Anthiya, S. et al. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01635-5
Read More
Check out our new OPEN ACCESS publication: ‘Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium’
March 13, 2024Marcos-Villar, L., Perdiguero, B., Anthiya, S. et al. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium. npj Vaccines 9, 53 (2024). https://doi.org/10.1038/s41541-024-00838-8.
Read More